Teijin Buys 10% Stake In Kyorin For $187.7 Million
This article was originally published in PharmAsia News
Executive Summary
Japan's Teijin, which has been sharing research and development with Kyorin Pharmaceutical for several years, said it had bought a 10% stake in the pharma from one of its major stakeholders to strengthen voting rights.